The Plenaxis® Experience Study
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-02-14
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT00103623
- Locations
- 🇺🇸
Alfred Sidhom, MD, FACS, PC, Anaheim, California, United States
🇺🇸Hematology-Oncology Group of Fresno, Fresno, California, United States
🇺🇸Urology Associates, P.C., Marietta, Georgia, United States
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2004-12-30
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00100334
- Locations
- 🇺🇸
Silverado Senior Living, San Juan Capistrano, California, United States
Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors
- Conditions
- Non-Hodgkin's Lymphoma,Solid Tumors
- First Posted Date
- 2004-12-30
- Last Posted Date
- 2007-07-25
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00100347
- Locations
- 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2004-12-28
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT00100282
- Locations
- 🇺🇸
Global Medical Institutes LLC, Princeton, New Jersey, United States
🇺🇸Department of Psychiatry & Human Behavior at the University California, Irvine, Orange, California, United States
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-12-28
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00100243
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Panama City Urological Center, Panama City, Florida, United States
🇺🇸Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States